Juha Grönlund

University of Turku — Finland

Medicine · Health Sciences

12h-index950citations20works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Management and Opioid Use(7), Cardiac Arrest and Resuscitation(5), Pharmacogenetics and Drug Metabolism(4), Traumatic Brain Injury and Neurovascular Disturbances(4), Pharmacological Effects and Toxicity Studies(4)

Publications19 total

Grey matter volume reduction and its association with brain-enriched blood biomarkers in out-of-hospital cardiac arrest survivors
Scientific Reports·2025Open Access
A metabolic profile of xenon and metabolite associations with 6-month mortality after out-of-hospital cardiac arrest: A post-hoc study of the randomised Xe-Hypotheca trial
PLoS ONE·2024· 3 citedOpen Access
The prevalence of cardiac complications and their impact on outcomes in patients with non-traumatic subarachnoid hemorrhage
Scientific Reports·2022· 9 citedOpen Access
Cerebral autoregulation after aneurysmal subarachnoid haemorrhage. A preliminary study comparing dexmedetomidine to propofol and/or midazolam
Acta Anaesthesiologica Scandinavica·2020· 9 citedOpen Access
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU
New England Journal of Medicine·2018· 327 citedOpen Access
Surviving out-of-hospital cardiac arrest: The neurological and functional outcome and health-related quality of life one year later
Resuscitation·2018· 41 citedOpen Access
Inhaled Xenon Attenuates Myocardial Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest
Journal of the American College of Cardiology·2017· 42 citedOpen Access
Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest
JAMA·2016· 137 citedOpen Access
Occurrence of Pressure Ulcers and Risk Factors in a Mixed Medical-Surgical ICU — A Cohort Study
Journal of the Intensive Care Society·2014· 14 cited
Feasibility and Cardiac Safety of Inhaled Xenon in Combination With Therapeutic Hypothermia Following Out-of-Hospital Cardiac Arrest*
Critical Care Medicine·2013· 72 cited
Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug–drug interactions
Pain Practice·2012· 1 cited
Effect of Cytochrome P450 2D6 and 3A Enzyme Inhibition on the Metabolism of Oxycodone
Doria (University of Helsinki)·2011
Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4
Antimicrobial Agents and Chemotherapy·2010· 31 cited
Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone
Clinical Drug Investigation·2010· 47 cited
Exposure to oral oxycodone is increased by simultaneous inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
European Journal of Anaesthesiology·2010Open Access
Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
British Journal of Clinical Pharmacology·2010· 81 citedOpen Access
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone
European Journal of Clinical Pharmacology·2010· 68 citedOpen Access
Effect of Telithromycin on the Pharmacokinetics and Pharmacodynamics of Oral Oxycodone
The Journal of Clinical Pharmacology·2009· 37 cited
Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease
Clinical & Experimental Immunology·2004· 24 citedOpen Access

Frequent Co-authors

Klaus T. Olkkola(12), Teijo I. Saari(8), Nora Hagelberg(7), Pertti J. Neuvonen(7), Ruut Laitio(5), Olli Arola(5), Risto O. Roine(5), Tero Vahlberg(5), Timo Laitio(5), Kari Laine(5), Minna Bäcklund(4), Marjaana Tiainen(4), Antti Saraste(4), Mikko Pietilä(4), Juhani Airaksinen(4), Harry Scheinin(4), Mervyn Maze(4), Marja Hynninen(3), Sami Virtanen(3), Riitta Parkkola(3)